Pure Global AI
MCA MCA-F-501

MCA-F-501/10, version 2 – 24 January 2025

Clinical Trial/Study Summary Report
GambiaMedicines Control Agency, The GambiaClinical TrialsCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MCA-F-501/10, version 2 – 24 January 2025 is the official MCA identifier for “Clinical Trial/Study Summary Report”. MCA-F-501/10, version 2 – 24 January 2025 is the official identifier MCA uses for this instrument.

Instrument
MCA-F-501
Full name
MCA-F-501/10, version 2 – 24 January 2025
Category
Clinical Trials
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Clinical Trial/Study Summary Report

Complete four-page clinical trial or study summary report, version 2 dated 24 January 2025. It covers design, participants, investigational products, accountability, end points, adverse events, modifications and overall results. The printed Stusy spelling and medicinal-product references are preserved. It does not set a national device marketing approval deadline or a general product-variation requirement. Later revisions and current applicability remain unverified.

MCA-F-501/10, version 2 – 24 January 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.